Neurochemical Metabolomics Reveals Disruption to Sphingolipid Metabolism Following Chronic Haloperidol Administration

Title
Neurochemical Metabolomics Reveals Disruption to Sphingolipid Metabolism Following Chronic Haloperidol Administration
Authors
Keywords
Metabolomics, Antipsychotics, Myelin, Sphingolipids, Extrapyramidal symptoms
Journal
Journal of Neuroimmune Pharmacology
Volume 10, Issue 3, Pages 425-434
Publisher
Springer Nature
Online
2015-04-07
DOI
10.1007/s11481-015-9605-1

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started